RESTON, Va., Aug. 4, 2014 /PRNewswire/ -- Leidos [NYSE: LDOS], a national security, health and engineering solutions company, was awarded a prime contract by the U.S. Army's Armament, Research, Development and Engineering Center (ARDEC). The multiple-award cost-plus-fixed-fee/firm fixed-price, indefinite delivery/indefinite quantity (IDIQ) contract has five-year period of performance and a contract ceiling of $300 million for all awardees. Leidos is one of seven awardees eligible to compete for task orders under the contract.
Under the contract, Leidos will provide processing, supply and fabrication of armament-related products, fabrication or refurbishment of armaments and related manufacturing equipment and prototyping and engineering services. Leidos will serve ARDEC through the Joint Munitions & Lethality Life Cycle Management Command (JM&L LCMC) program office.
ARDEC's mission is to rapidly respond to soldier needs for armament-related products and services. The contract streamlines ARDEC's procurement strategy through JM&L LCMC to accomplish their mission and ensure the fast delivery of armament and weapons systems from research and development facilities to the field for current military efforts.
"This contract offers Leidos the opportunity to support a new program office— the JM&L LCMC—with our advanced engineering and technology expertise," said Leidos Engineering Solutions Group President, James R. Moos. "Our efforts for ARDEC are critical to effectively and quickly responding to soldiers' armament-related, high-priority field needs."
Leidos is a FORTUNE 500® science and technology solutions leader working to address some of the world's toughest challenges in national security, health and engineering. The Company's 22,000 employees support vital missions for our government and the commercial sector, develop innovative solutions to drive better outcomes, and defend our Nation's digital and physical infrastructure from 'new world' threats. Headquartered in Reston, Va., Leidos reported annual revenues of approximately $5.77 billion for its fiscal year ended January 31, 2014, after giving effect to the spin-off of the company's technical services and information technology business. For more information, visit www.Leidos.com.
Statements in this announcement, other than historical data and information, constitute forward-looking statements that involve risks and uncertainties. A number of factors could cause our actual results, performance, achievements, or industry results to be very different from the results, performance, or achievements expressed or implied by such forward-looking statements. Some of these factors include, but are not limited to, the risk factors set forth in the company's Annual Report on Form 10-K for the period ended January 31, 2014, and other such filings that Leidos makes with the SEC from time to time. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof.